The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

A new mental health and substance abuse treatment facility in Chambers County, Alabama faces opposition from the Birmingham-based Bradford Behavioral Health - a leading substance use disorder ("SUD") ...

Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...

Citi Pharma Limited (CPHL), a Pakistani pharmaceutical company, has decided to venture into the real estate sector with the ...

Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the US, including Bevacizumab in oncology, insulin Aspart in diabetes, and ...

Insulin allows cells to absorb and use glucose. In people with insulin resistance, the cells are unable to use insulin effectively. Insulin resistance occurs when cells in the body do not respond ...

The efficacy benefits of biphasic insulin aspart formulation (BIAsp 30) in patients with diabetes mellitus have been reported in several studies. BIAsp 30 has been shown to be more effective in ...

The current review has used an EBM approach to evaluate the strength and validity of the evidence supporting the clinical efficacy and tolerability and the administration benefits of insulin ...

The first round of talks, which yielded prices set to take effect in 2026, included insulin aspart, which Novo sells as several different products. That selection triggered a lawsuit from Novo ...

The first round of talks, which yielded prices set to take effect in 2026, included insulin aspart, which Novo sells as several different products. That selection triggered a lawsuit from Novo, citing ...